Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
Prelaj, Arsela, Bottiglieri, Achille, Proto, Claudia, Lo Russo, Giuseppe, Signorelli, Diego, Ferrara, Roberto, Galli, Giulia, De Toma, Alessandro, Viscardi, Giuseppe, Brambilla, Marta, Lobefaro, Riccardo, Nichetti, Federico, Manglaviti, Sara, Occhipinti, Mario, Labianca, Alice, Ganzinelli, Monica, Gallucci, Rosaria, Zilembo, Nicoletta, Greco, Gabriella Francesca, Torri, Valter, de Braud, Filippo, Garassino, Marina C.
Published in European journal of cancer (1990) (01.05.2021)
Published in European journal of cancer (1990) (01.05.2021)
Get full text
Journal Article
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications
Vernieri, Claudio, Corti, Francesca, Nichetti, Federico, Ligorio, Francesca, Manglaviti, Sara, Zattarin, Emma, Rea, Carmen G, Capri, Giuseppe, Bianchi, Giulia V, de Braud, Filippo
Published in Breast cancer research : BCR (06.04.2020)
Published in Breast cancer research : BCR (06.04.2020)
Get full text
Journal Article
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
Prelaj, Arsela, Bottiglieri, Achille, Bhat, Gajanan, Washington, Rocky, Calareso, Giuseppina, Greco, Gabriella Francesca, Ferrara, Roberto, Brambilla, Marta, De Toma, Alessandro, Occhipinti, Mario, Manglaviti, Sara, Soro, Alberto, Ganzinelli, Monica, Lo Russo, Giuseppe, Proto, Claudia
Published in Frontiers in oncology (08.06.2022)
Published in Frontiers in oncology (08.06.2022)
Get full text
Journal Article
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
Prelaj, Arsela, Galli, Edoardo Gregorio, Miskovic, Vanja, Pesenti, Mattia, Viscardi, Giuseppe, Pedica, Benedetta, Mazzeo, Laura, Bottiglieri, Achille, Provenzano, Leonardo, Spagnoletti, Andrea, Marinacci, Roberto, De Toma, Alessandro, Proto, Claudia, Ferrara, Roberto, Brambilla, Marta, Occhipinti, Mario, Manglaviti, Sara, Galli, Giulia, Signorelli, Diego, Giani, Claudia, Beninato, Teresa, Pircher, Chiara Carlotta, Rametta, Alessandro, Kosta, Sokol, Zanitti, Michele, Di Mauro, Maria Rosa, Rinaldi, Arturo, Di Gregorio, Settimio, Antonia, Martinetti, Garassino, Marina Chiara, de Braud, Filippo G M, Restelli, Marcello, Lo Russo, Giuseppe, Ganzinelli, Monica, Trovò, Francesco, Pedrocchi, Alessandra Laura Giulia
Published in Frontiers in oncology (23.01.2023)
Published in Frontiers in oncology (23.01.2023)
Get full text
Journal Article
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group
Antonarelli, Gabriele, Corti, Chiara, Zucali, Paolo Andrea, Perrino, Matteo, Manglaviti, Sara, Lo Russo, Giuseppe, Varano, Gianluca Maria, Salvini, Piermario, Curigliano, Giuseppe, Catania, Chiara, Conforti, Fabio, De Pas, Tommaso
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs
Leporati, Rita, Miliziano, Daniela, Beninato, Teresa, Mazzeo, Laura, Manglaviti, Sara, Brambilla, Marta, Occhipinti, Mario, Prelaj, Arsela, Proto, Claudia, Lo Russo, Giuseppe
Published in Tumori (16.04.2024)
Published in Tumori (16.04.2024)
Get more information
Journal Article
Immunotherapy and chemo-immunotherapy for non–small cell lung cancer with novel actionable oncogenic driver alterations
Mazzeo, Laura, Beninato, Teresa, Pircher, Chiara Carlotta, Brambilla, Marta, Manglaviti, Sara, De Toma, Alessandro, Galli, Giulia, Prelaj, Arsela, Ferrara, Roberto, Proto, Claudia, Lo Russo, Giuseppe, Ganzinelli, Monica, Garassino, Marina Chiara, Marchetti, Paolo, De Braud, Filippo G., Occhipinti, Mario
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Concurrent chemoradiation for non-metastatic anal carcinoma: A case series from a single institution experience
Lobefaro, Riccardo, Cavalieri, Stefano, Nichetti, Federico, Manglaviti, Sara, Villa, Sergio, De Braud, Filippo G., Platania, Marco
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Unleashing precision: A review of targeted approaches in pleural mesothelioma
Occhipinti, Mario, Brambilla, Marta, Di Liello, Raimondo, Ambrosini, Paolo, Lobianco, Lorenzo, Leporati, Rita, Salvarezza, Maria, Vitiello, Fabiana, Marchesi, Silvia, Manglaviti, Sara, Beninato, Teresa, Mazzeo, Laura, Proto, Claudia, Prelaj, Arsela, Ferrara, Roberto, Della Corte, Carminia Maria, Lo Russo, Giuseppe, de Braud, Filippo, Ganzinelli, Monica, Viscardi, Giuseppe
Published in Critical reviews in oncology/hematology (01.11.2024)
Published in Critical reviews in oncology/hematology (01.11.2024)
Get full text
Journal Article
Erratum to “Unleashing precision: A review of targeted approaches in pleural mesothelioma” [Crit. Rev. Oncol./Hematol. 203C (2024) 104481]
Occhipinti, Mario, Brambilla, Marta, Di Liello, Raimondo, Ambrosini, Paolo, Lobianco, Lorenzo, Leporati, Rita, Salvarezza, Maria, Vitiello, Fabiana, Marchesi, Silvia, Manglaviti, Sara, Beninato, Teresa, Mazzeo, Laura, Proto, Claudia, Prelaj, Arsela, Ferrara, Roberto, Della Corte, Carminia Maria, Lo Russo, Giuseppe, de Braud, Filippo, Ganzinelli, Monica, Viscardi, Giuseppe
Published in Critical reviews in oncology/hematology (23.09.2024)
Published in Critical reviews in oncology/hematology (23.09.2024)
Get full text
Journal Article
Risk of disease progression (PD) following discontinuation of BRAF±MEK targeted therapies for reasons other than PD in patients (pts) with metastatic or unresectable melanoma
Corti, Francesca, Randon, Giovanni, Bini, Marta, Raimondi, Alessandra, Manglaviti, Sara, Zattarin, Emma, Bisogno, Ilaria, Vetrano, Irene, Cimminiello, Carolina, De Braud, Filippo G., Del Vecchio, Michele, Di Guardo, Lorenza
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
Giugliano, Federica, Zucali, Paolo A., Galli, Giulia, Ballatore, Zelmira, Corti, Chiara, Aliaga, Pamela T., Uliano, Jacopo, Vivanet, Grazia, Curigliano, Giuseppe, Conforti, Fabio, Queirolo, Paola, Berardi, Rossana, Manglaviti, Sara, Apollonio, Giulia, Perrino, Matteo, Borea, Federica, D'Antonio, Federica, Garassino, Marina C., De Pas, Tommaso
Published in European journal of cancer (1990) (01.05.2022)
Published in European journal of cancer (1990) (01.05.2022)
Get full text
Journal Article
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 < 50%: A multiomics approach
Garassino, Marina Chiara, Proto, Claudia, Dolezal, James M, Prelaj, Arsela, Agnelli, Luca, Triulzi, Tiziana, Fabbri, Alessandra, Ferrara, Roberto, Sgambelluri, Francesco, Torelli, Tommaso, Brich, Silvia, Manglaviti, Sara, Anichini, Andrea, Mortarini, Roberta, Trinchieri, Giorgio, Pruneri, Giancarlo, De Braud, Filippo G., Torri, Valter, Ganzinelli, Monica, Lo Russo, Giuseppe
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
PEOPLE (NTC03447678), a phase II trial of first-line, single-agent pembrolizumab in advanced NSCLC with low PD-L1: Clinical outcomes and association with circulating immune biomarkers
Lo Russo, Giuseppe, Ganzinelli, Monica, Sgambelluri, Francesco, Galli, Francesca, Prelaj, Arsela, Manglaviti, Sara, Bottiglieri, Achille, Di Mauro, Rosa Maria, Ferrara, Roberto, Dumitrascu, Andra Diana, Sottotetti, Elisa, Martinetti, Antonia, Fabbri, Alessandra, Rulli, Eliana, De Braud, Filippo G., Torri, Valter, Garassino, Marina Chiara, Anichini, Andrea, Proto, Claudia, Mortarini, Roberta
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Proto, Claudia, Manglaviti, Sara, Lo Russo, Giuseppe, Musca, Marco, Galli, Giulia, Imbimbo, Martina, Perrino, Matteo, Cordua, Nadia, Rulli, Eliana, Ballatore, Zelmira, Dal Maso, Alessandro, Chella, Antonio, Sbrana, Andrea, Prelaj, Arsela, Ferrara, Roberto, Occhipinti, Mario, Brambilla, Marta, De Toma, Alessandro, Mazzeo, Laura, Beninato, Teresa, Signorelli, Diego, Massa, Giacomo, Greco, Francesca Gabriella, Calareso, Giuseppina, Miliziano, Daniela, Di Mauro, Rosa Maria, Mella, Giulia, Lucarelli, Alessandra, Paggio, Angela, Galli, Francesca, Torri, Valter, de Braud, Filippo Guglielmo Maria, Pasello, Giulia, Petrini, Iacopo, Berardi, Rossana, Ganzinelli, Monica, Garassino, Marina Chiara, Zucali, Paolo Andrea
Published in Journal of thoracic oncology (01.08.2023)
Published in Journal of thoracic oncology (01.08.2023)
Get full text
Journal Article
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors
Manglaviti, Sara, Bini, Marta, Apollonio, Giulia, Zecca, Ernesto, Galli, Giulia, Sangaletti, Sabina, Labianca, Alice, Sottotetti, Elisa, Brambilla, Marta, Occhipinti, Mario, Proto, Claudia, Prelaj, Arsela, Signorelli, Diego, De Toma, Alessandro, Viscardi, Giuseppe, Beninato, Teresa, Mazzeo, Laura, Bottiglieri, Achille, Leporati, Rita, Fotia, Giuseppe, Ganzinelli, Monica, Portararo, Paola, Garassino, Marina Chiara, de Braud, Filippo G M, Lo Russo, Giuseppe, Torri, Valter, Ferrara, Roberto
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2023)
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2023)
Get full text
Journal Article
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study
Cantini, Luca, Paoloni, Francesco, Pecci, Federica, Spagnolo, Francesco, Genova, Carlo, Tanda, Enrica Teresa, Aerts, Sophie, Rebuzzi, Sara Elena, Fornarini, Giuseppe, Zoratto, Federica, Fancelli, Sara, Lupi, Alessio, Della Corte, Carminia Maria, Parisi, Alessandro, Bennati, Chiara, Ortega, Cinzia, Atzori, Francesco, Piovano, Pier Luigi, Orciuolo, Corrado, De Tursi, Michele, Ghidini, Michele, Botticelli, Andrea, Scagnoli, Simone, Belluomini, Lorenzo, Leporati, Rita, Veccia, Antonello, Di Giacomo, Anna Maria, Festino, Lucia, Cortinovis, Diego, Acquati, Mirko, Filetti, Marco, Giusti, Raffaele, Tucci, Marco, Sergi, Maria Chiara, Garutti, Mattia, Puglisi, Fabio, Manglaviti, Sara, Citarella, Fabrizio, Santoni, Matteo, Rijavec, Erika, Lo Russo, Giuseppe, Santini, Daniele, Addeo, Alfredo, Antonuzzo, Lorenzo, Indini, Alice, Rocchi, Marco Bruno Luigi, Cortellini, Alessio, Grossi, Francesco, Ascierto, Paolo Antonio, Aerts, Joachim G J V, Berardi, Rossana
Published in JNCI : Journal of the National Cancer Institute (06.07.2023)
Published in JNCI : Journal of the National Cancer Institute (06.07.2023)
Get full text
Journal Article
Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor)
Gasperoni, Silvia, Castiglione, Francesca, Vannucchi, Margherita, Papi, Laura, Fumagalli, Elena, Manglaviti, Sara, Vincenzi, Bruno, Mazzocca, Alessandro, Nannini, Margherita, Vancheri, Giovanni, Adragna, Tommaso, Ottaviano, Margaret, Palmieri, Giovannella, Meoni, Giulia, Ribecco, Angela Stefania, Grignani, Giovanni, Tolomeo, Francesco, Tofani, Lorenzo, Paderi, Agnese, Mini, Enrico
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy
Zattarin, Emma, Manglaviti, Sara, Apollonio, Giulia, Beninato, Teresa, Mazzeo, Laura, Massa, Giacomo, Bottiglieri, Achille, Galli, Edoardogregorio, De Toma, Alessandro, Occhipinti, Mario, Brambilla, Marta, Ferrara, Roberto, Ganzinelli, Monica, Proto, Claudia, Garassino, Marina Chiara, de Braud, Filippo, Lo Russo, Giuseppe, Prelaj, Arsela
Published in Future oncology (London, England) (01.07.2022)
Published in Future oncology (London, England) (01.07.2022)
Get full text
Journal Article